Objectives: We aimed to compare the associations of directly measured plasma free 25-hydroxyvitamin D [25(OH)D] and total 25(OH)D concentrations with insulin sensitivity (S I ) and b-cell function in nondiabetic Hispanics and African Americans. We hypothesized that directly measured free 25(OH)D would be more strongly associated with these measures of glucose homeostasis and that associations would differ by race.
I
t is well established that insulin resistance and pancreatic b-cell dysfunction are central pathophysiological mechanisms underlying type 2 diabetes (T2DM). Experimental evidence in animal models and cell lines has suggested that vitamin D metabolites may exert beneficial effects on b-cell function and insulin sensitivity (S I ) through a variety of mechanisms, subsequently modifying risk for T2DM development (1) . However, epidemiologic research on the association between plasma total 25-hydroxyvitamin D [25(OH)D] and incident T2DM has been inconsistent. Although metaanalyses of prospective cohort studies have reported significant associations of low plasma total 25(OH)D concentrations with incident T2DM (2, 3), findings have been less consistent among African Americans (4), a phenomenon that may be due to lower plasma concentrations of total 25(OH)D in this population (5) . In addition, randomized controlled trials testing the efficacy of vitamin D supplementation on improving S I or b-cell function, or preventing T2DM, have been highly inconsistent to date (6) .
A large proportion of 25(OH)D in the circulation is bound to vitamin D-binding protein and albumin, with a very small fraction circulating in the unbound, or free, form (7) . Under the free hormone hypothesis, it has been proposed that it is the free fraction of hormones that exerts biological activity (8) . Indeed, emerging data from studies of bone mineral density have suggested that plasma free 25(OH)D may be a superior marker of vitamin D metabolism compared with measures of the total metabolite (9) (10) (11) . In addition, a recent study reported similar plasma concentrations of free 25(OH)D in white and African American subjects, despite significantly lower plasma concentrations of total 25(OH)D in the latter group (12) . These observations are of interest given inconsistencies in the literature on vitamin D in T2DM etiology, especially among African Americans. However, to our knowledge, the association of plasma free 25(OH)D with T2DM and its underlying abnormalities has not been reported. In addition, most previous studies have not directly measured free 25(OH)D, instead relying on estimates derived from published formulae that include total 25(OH)D, albumin, and vitamin D-binding protein (9) (10) (11) .
In this context, we compared the associations of directly measured plasma free and total 25(OH)D concentrations with S I , acute insulin response (AIR), disposition index (DI), and homeostatic model assessment of insulin resistance (HOMA-IR). We used data from a large, well-characterized cohort of Hispanics and African Americans with direct measurements of insulin metabolism (secretion and sensitivity) and adipose tissue depots (visceral and subcutaneous) in the Insulin Resistance Atherosclerosis Study (IRAS) Family Study. We hypothesized that plasma free 25(OH)D concentrations would show stronger associations with glucose homeostasis outcomes compared with plasma total 25(OH)D concentrations and that plasma free 25(OH)D would be particularly useful in understanding the vitamin D-T2DM link among African Americans.
Methods and Materials

Study population
This study used data from the IRAS Family Study, which recruited large families between 2000 and 2002 at study centers in San Antonio, Texas (Hispanics), San Luis Valley, Colorado (Hispanics), and Los Angeles, California (African Americans), with probands identified from the parent study (IRAS) and the general population. Details of the study population and methods have been published (13) . The institutional review boards approved the study protocol, and all participants provided written informed consent. A total of 1856 participants attended baseline examinations. After excluding those with prevalent diabetes at baseline (n = 229) and those with missing values of directly measured plasma free 25(OH)D, total 25(OH)D, S I , AIR, DI, or HOMA-IR at baseline (n = 9), the sample size of the current report was 1189 participants.
Data collection
Demographic data (e.g., age, sex, and ethnicity) and lifestyle factors (e.g., smoking and alcohol consumption) were collected on standardized questionnaires by self-report (13) . Physical activity was self-reported in a 1-year recall using a modified version of a validated instrument that incorporated activities common among participants in the IRAS Family Study. Total energy expenditure (in kcal/kg/y) was the sum of all activities at home, work, or leisure time, estimated energy expenditure from sleep, and estimated energy expenditure from light activities (13, 14) . Season of blood draw was determined from the date of the baseline visit. Blood draws taken from December to May were categorized as winter/spring and those taken from June to November were categorized as summer/fall (15) . Anthropometric (e.g., height, weight, and waist circumference) and blood pressure measurements were taken using standardized procedures. Body mass index (BMI) was calculated as weight in kg divided by height in m 2 (13) . Duplicate measurements were made, and averages were used in the analyses.
Biochemical analyses
Participants provided a fasting blood draw at each examination. Plasma insulin was measured by dextran-charcoal radioimmunoassay (16) . Plasma glucose was determined on an auto-analyzer using the glucose oxidase method. Prevalent diabetes at baseline was defined as fasting glucose $126 mg/dL or use of antidiabetic medications by self-report.
Measurement of plasma 25(OH)D concentrations
Plasma free 25(OH)D was measured by a two-step enzymelinked immunosorbent assay (DIASource, Louvain-La-Neuve, Belgium) in blood samples collected at baseline. During the first incubation step, free 25(OH)D binds to the monoclonal anti-vitamin D in the microtiter plate. The microtiter plate is then washed, and a fixed amount of biotinylated 25(OH) is added to allow it to react with the remaining antibody in the second incubation. This incubation is followed by another wash and quantitation of the absorbance, which is inversely proportional to the level of free 25(OH)D in the samples. The interassay coefficient of variation for plasma free 25(OH)D was 24%. Plasma total 25(OH)D was measured by a two-step procedure involving a rapid extraction of 25(OH)D and other hydroxylated metabolites from plasma and a radioimmunoassay with a 25(OH)D-specific antibody (DIASorin, Stillwater, MN) with an interassay coefficient of variation ,8% (17).
Measurement of S I and insulin secretion
S I was determined using a frequently sampled intravenous glucose tolerance test, with two modifications to the original protocol (18) . First, insulin, instead of tolbutamide, was injected to ensure adequate levels of plasma insulin for accurate calculation of S I across a broad range of glucose tolerance (19) . Second, a reduced sampling protocol, using 12 instead of 30 samples, was used because of the large number of participants (20) . S I , expressed as the S I , was calculated using minimal model analysis (21) . HOMA-IR was calculated according to the method by Matthews et al. (22) . Insulin secretion was measured by AIR, defined as the average increase in plasma insulin above the basal level in the first 8 minutes after infusing glucose (23) . DI was defined as S I multiplied by AIR (24) . DI differs from S I and HOMA-IR in that it is an integrated measure of insulin secretion that takes account of the background S I . Thus it is thought to be a more appropriate measure of b-cell response.
Measurement of adipose tissue depots
Abdominal fat mass was measured by computed tomography using a standardized protocol at each clinical center. The computed tomography scans were read centrally at the University of Colorado Health Sciences Center, Department of Radiology, Bio-Imaging Research Laboratory. Images obtained at the L4/L5 vertebral regions were used to determine the area of subcutaneous adipose tissue (SAT) and visceral adipose tissue (VAT). Bowel fat was subtracted from the measurements of VAT (25, 26) .
Statistical analyses
We described the characteristics of participants at baseline (overall and separately by ethnicity), stratified by thirds of the distribution of plasma free 25(OH)D, using medians and interquartile ranges for continuous variables and percentages for categorical variables. We used analysis of variance, Kruskal-Wallis tests, and x 2 tests to determine whether continuous and categorical variables differed across the distribution of plasma free 25(OH)D. We used Spearman correlation to determine the relationship between plasma free and total 25(OH)D concentrations.
Because the distributions of S I , AIR, and DI were skewed, we applied the following transformations to achieve normality for subsequent analyses: signed square root of AIR and DI and natural log-transformation of S I . Because of the presence of 0 values for S I , we added a constant of 1 to all values of S I before the log-transformation. We used unadjusted and multivariableadjusted generalized estimating equations (GEEs), which accounted for the family structure of the cohort, to examine the cross-sectional associations of plasma free and total 25(OH)D with S I , AIR, DI, and HOMA-IR.
We presented the regression coefficients (b) for GEE along with their 95% confidence intervals (CIs) per 1 standard deviation (SD) increase in plasma free or total 25(OH)D. We included covariates in multivariable-adjusted models if they were associated with both the exposure and the outcome, or if there was a priori clinical relevance. Potential confounders included age, sex, ethnicity, smoking, season of blood draw, and BMI. We tested for effect modification by ethnicity and BMI on the associations of plasma free and total 25(OH)D on the outcomes of S I , AIR, DI, and HOMA-IR. We used the quasilikelihood under the independence model criterion (QIC) program in STATA to determine whether plasma free 25(OH)D or total 25(OH)D was a better model fit for the outcomes. The lower the QIC value, the better the model fit. A P value of ,0.05 for the interaction term suggested a significant effect modification.
In sensitivity analyses, we adjusted for VAT, SAT, or waist circumference instead of BMI in GEE models to explore whether there was any difference in the magnitudes of association after considering different adiposity measures as covariates. We also additionally adjusted for fasting blood glucose to determine its impact on the overall association in all outcomes. All statistical analyses were performed using STATA 12.0 (StataCorp, College Station, TX).
Results
Of the 1189 nondiabetic participants in this analysis, 63% were Hispanics (n = 747), 37% were African Americans (n = 442), and, overall, 57% were women. The median age of these participants was 39 years (interquartile range, 30 to 47 years). The median concentrations of plasma free 25(OH)D were 2.98 pg/mL (interquartile range, 1.93 to 4.21 pg/mL) for the entire cohort, 3.46 pg/mL (interquartile range, 2.45 to 4.71 pg/mL) for Hispanics, and 2.17 pg/mL (interquartile range, 1.43 to 3.23 pg/mL) for African Americans (ethnic difference, P , 0.0001). The median concentrations of plasma total 25(OH)D were 13 ng/mL (interquartile range, 9 to 19 ng/mL) for the entire cohort, 16 ng/mL (interquartile range, 11 to 21 ng/mL) for Hispanics, and 10 ng/mL (interquartile range, 7 to 14 ng/mL) for African Americans (ethnic difference, P , 0.0001). The frequency distributions of plasma free and total 25(OH) vitamin D according to ethnicity are shown in Figs. 1 and 2 , respectively.
Participants who had higher plasma levels of free 25(OH) vitamin D were more likely to be male and have lower BMI, waist circumference, and SAT and higher energy expenditure. These participants also had higher S I and DI as well as lower fasting blood glucose concentrations and HOMA-IR (Table 1 ). These patterns were largely similar when Hispanics and African Americans were examined separately (Supplemental Tables 1 and 2 Table 3 ).
In unadjusted GEE models, plasma free 25(OH)D was positively associated with S I and negatively associated with HOMA-IR. The significant associations remained after adjusting for age, sex, ethnicity, smoking, energy expenditure, season of blood draw, and BMI. Plasma free 25(OH)D was positively associated with DI in unadjusted GEE models and after adjusting for demographic and lifestyle factors. The association was attenuated after adjustment of BMI but remained statistically significant. There was no association between plasma free 25(OH)D and AIR and S I -adjusted AIR in both unadjusted and multivariable-adjusted GEE models (Table 2) . Plasma total 25(OH)D was positively associated with S I and DI and negatively associated with HOMA-IR in GEE models that were adjusted for demographic and lifestyle factors. Further adjustment of BMI attenuated the associations to nonsignificance. Plasma total 25(OH)D was not associated with AIR or S I -adjusted AIR (Table 3) There was no effect modification by ethnicity on any of the exposure-outcome associations. In sensitivity analyses, replacing BMI in the fully adjusted models for alternate measures of adiposity, including waist circumference, VAT, or SAT, did not impact the results materially (Supplemental Tables 4 and  5 ). Additional adjustment for fasting blood glucose in multivariable-adjusted GEEs did not change the overall association for any of the outcomes.
Discussion
Recent studies have reported that free 25(OH)D levels are more strongly associated with measures of bone mineral density and metabolism than levels of total 25(OH)D (9) (10) (11) , observations that are consistent with the free hormone hypothesis (8) . In light of these findings, as well as the inconsistencies in published results regarding (12) , our overarching hypothesis in the current study was that free 25(OH)D concentrations would be more strongly associated than total concentrations with S I and b-cell function. We addressed this hypothesis in a cohort of African Americans and Hispanics who had been extensively characterized, including direct assessment of S I and secretion from the frequently sampled intravenous glucose tolerance test. An additional unique aspect of this work was the use of a recently developed assay from DIASource, which allows for the direct measurement of free 25(OH)D concentrations (27) . The majority of previous studies assessing the impact of free 25(OH)D have estimated concentrations of this form of the metabolite using published formulae (9) (10) (11) (12) .
Our results show that both free and total 25(OH)D concentrations were significantly associated with S I (S I and HOMA-IR) and b-cell function (DI) but not with insulin secretion (AIR) in models adjusted for age, sex, ethnicity, smoking, energy expenditure, and season. The associations with free 25(OH)D were slightly stronger in magnitude compared with total 25(OH)D, despite the larger coefficient of variation for the free 25(OH)D assay (Tables 2 and 3 (12) . This study is not directly comparable to ours for a number of reasons, including differences in the composition of the study populations, most notably the inclusion of Hispanics in our study. In addition, the methods for measuring free 25(OH)D were different between the two studies. We used a recently developed assay that directly measures (29) (30) (31) (32) (33) (34) . In addition, the directly measured free 25(OH)D assay had a high coefficient of variation. It is clear that a substantial amount of additional research is needed to clarify optimal approaches for the measurement of free 25(OH)D.
The strengths of the IRAS Family Study include the well-characterized prospective cohort of Hispanics and African Americans, two ethnic groups that are at high risk of developing diabetes, the detailed measurements of S I , insulin secretion, and adiposity, and the availability of directly measured (vs calculated) plasma free 25(OH)D. Nevertheless, several potential limitations should also be considered. Without oral glucose tolerance tests, some individuals with elevated postprandial glucose levels may have been misclassified as not having diabetes. Plasma total 25(OH)D was measured by radioimmunoassay instead of the gold standard of liquid chromatography-tandem mass spectrometry. The low precision of the radioimmunoassay method may have impacted the magnitude of associations observed. In addition, the cross-sectional design of this study does not allow us to exclude the possibility of residual confounding. Finally, the results of this study may not be generalizable to other populations.
In conclusion, plasma free 25(OH)D was significantly associated with S I in the IRAS Family Study cohort. Both free and total 25(OH)D were low in African Americans based on direct measurement. Although the free form of plasma 25(OH)D appeared to have a modestly stronger association vs the total form of plasma 25(OH)D, additional research is needed to confirm this observation. 
